(Q78282327)

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/j.bmcl.2011.04.042

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Selective cholinesterase inhibition by lanostane triterpenes from fruiting bodies of Ganoderma lucidum (English)

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/j.bmcl.2011.04.042

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

2 references

ChEBI release 2020-05-28

1 reference

1 reference

methyl ganoderate A acetonide

1 reference

(4R)-4-[(3S,5R,7S,10S,13R,14R,17R)-3,7-dihydroxy-4,4,10,13,14-pentamethyl-11-oxo-1,2,3,5,6,7,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid

1 reference

1 reference

(5R,10S,13R,14R,17R)-17-[(2R,5S)-6-hydroxy-5,6-dimethylheptan-2-yl]-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one

1 reference

1 reference

1 reference

1 reference

15-Hydroxy-3,11,23-trioxolanost-8-en-26-oic acid

1 reference

1 reference

Lanosta-7,9(11),24-trien-26-oic acid, 3-hydroxy-, (3beta,24E)-

1 reference

methyl (2R,6R)-6-[(5R,7S,10S,13R,14R,15S,17R)-7,15-dihydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methyl-4-oxoheptanoate

1 reference

methyl (4R)-4-[(5R,7S,10S,13R,14R,17R)-7-hydroxy-4,4,10,13,14-pentamethyl-3,11-dioxo-2,5,6,7,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate

1 reference

1 reference

cholinesterase inhibition

1 reference

1 reference

1 reference

Lanosta-7,9(11)-diene-3,24,25-triol

1 reference

(5R,10S,13R,14R,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-4,4,10,13,14-pentamethyl-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

1 reference

Masao Hattori

4

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/j.bmcl.2011.04.042

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Iksoo Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Bora Ahn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Jaesue Choi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Byungsun Min

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Kihwan Bae

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

12 February 2020

publication date

November 2011

1 reference

16 September 2022

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/j.bmcl.2011.04.042

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

21

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/j.bmcl.2011.04.042

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

21

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/j.bmcl.2011.04.042

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

6603-6607

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/j.bmcl.2011.04.042

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

Structures of Ganoderic Acid A and B, Two New Lanostane Type Bitter Triterpenes fromGanoderma lucidum (FR.) KARST.

12 February 2020

cites work

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/HLCA.19820650221

New Acetylcholinesterase-Inhibitory Pregnane Glycosides of Cynanchum atratum Roots

9 March 2024

1 reference

9 March 2024

https://opencitations.net/index/api/v1/citations/10.1002/HLCA.200390047

Novel triterpenoids from the fungus Ganoderma lucidum.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB1961.52.367

New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi).

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1271/BBB1961.49.1793

Cholinesterase inhibitory constituents from Onosma hispida

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.51.412

Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.46.1607

Constituents of the fungus Ganoderma lucidum (Fr.) Karst. II Structures of ganoderic acids F, G, and H, lucidenic acids D2 and E2, and related compounds.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.34.4018

Constituents of the fungus Ganoderma lucidum (Fr.) Karst. I Structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.34.3695

Structures of new terpenoid constituents of Ganoderma lucidum (Fr.) KARST (Polyporaceae).

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.33.4829

Ganoderic acid G and I and ganolucidic acid A and B, new triterpenoids from Ganoderma lucidum.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.33.2628

The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.33.1367

(+)-Alpha-viniferin, a stilbene trimer from Caragana chamlague, inhibits acetylcholinesterase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/BPB.25.125

Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/BPB.22.162

Identifiers

2 references

https://api.crossref.org/v1/works/http://dx.doi.org/10.1016/j.bmcl.2011.04.042

13 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21924611%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference